Yuri Bobryshev

Dr. Yuri Bobryshev


Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2017 in Laboratory Investigation
Verified
Journal Article
Closed access
DCDimitry A Chistiakov
Dimitry A Chistiakov
MKMurry C Killingsworth
Murry C Killingsworth
VMVeronika Myasoedova
Veronika Myasoedova
AOAlexander N Orekhov
Alexander N Orekhov
YBYuri Bobryshev
Yuri Bobryshev

23 October 2015 in Journal of Cellular and Molecular Medicine
Verified
Journal Article
Open access
PDF file
DCDimitry A. Chistiakov
Dimitry A. Chistiakov
YBYuri Bobryshev
Yuri Bobryshev
AOAlexander N. Orekhov
Alexander N. Orekhov
Formation of foam cells is a hallmark at the initial stages of atherosclerosis. Monocytes attracted by pro‐inflammatory stimuli attach to the inflamed vascular endothelium and penetrate to the arterial intima where they differentiate to macrophages. Intimal macrophages phagocytize oxidized low‐density lipoproteins (oxLDL). Several scavenger receptors (SR), including CD36, SR‐A1 and lectin‐like oxLDL receptor‐1 (LOX‐1), mediate oxLDL uptake. In late endosomes/lysosomes of macrophages, oxLDL are catabolysed. Lysosomal acid lipase (LAL) hydrolyses cholesterol esters that are enriched in LDL to free cholesterol and free fatty acids. In the endoplasmic reticulum (ER), acyl coenzyme A: cholesterol acyltransferase‐1 (ACAT1) in turn catalyses esterification of cholesterol to store cholesterol esters as lipid droplets in the ER of macrophages. Neutral cholesteryl ester hydrolases nCEH and NCEH1 are involved in a secondary hydrolysis of cholesterol esters to liberate free cholesterol that could be then out‐flowed from macrophages by cholesterol ATP‐binding cassette (ABC) transporters ABCA1 and ABCG1 and SR‐BI. In atherosclerosis, disruption of lipid homoeostasis in macrophages leads to cholesterol accumulation and formation of foam cells.

1 January 2014 in BioMed Research International
Verified
Journal Article
Open access
PDF file
DCDimitry A. Chistiakov
Dimitry A. Chistiakov
ISIgor Sobenin
Igor Sobenin
Viktor RevinViktor Revin
Viktor Revin
Alexander N. OrekhovAlexander N. Orekhov
Alexander N. Orekhov
YBYuri Bobryshev
Yuri Bobryshev
Age-related changes in mitochondria are associated with decline in mitochondrial function. With advanced age, mitochondrial DNA volume, integrity and functionality decrease due to accumulation of mutations and oxidative damage induced by reactive oxygen species (ROS). In aged subjects, mitochondria are characterized by impaired function such as lowered oxidative capacity, reduced oxidative phosphorylation, decreased ATP production, significant increase in ROS generation, and diminished antioxidant defense. Mitochondrial biogenesis declines with age due to alterations in mitochondrial dynamics and inhibition of mitophagy, an autophagy process that removes dysfunctional mitochondria. Age-dependent abnormalities in mitochondrial quality control further weaken and impair mitochondrial function. In aged tissues, enhanced mitochondria-mediated apoptosis contributes to an increase in the percentage of apoptotic cells. However, implementation of strategies such as caloric restriction and regular physical training may delay mitochondrial aging and attenuate the age-related phenotype in humans.

1 June 2016 in Acta Physiologica
Verified
Journal Article
Closed access
PDF file
DCD. A. Chistiakov
D. A. Chistiakov
AOA. N. Orekhov
A. N. Orekhov
YBYuri Bobryshev
Yuri Bobryshev

25 February 2015 in Acta Physiologica
Verified
Journal Article
Closed access
PDF file
DCD. A. Chistiakov
D. A. Chistiakov
AOA. N. Orekhov
A. N. Orekhov
YBYuri Bobryshev
Yuri Bobryshev

1 April 2006 in Micron
Verified
Journal Article
Closed access
YBYuri Bobryshev
Yuri Bobryshev